Tegretol Prolonged Release (carbamazepine): Reviews and patient testimonials


Medication indications

Tegretol Prolonged Release 200mg and 400mg Tablets

Epilepsy - generalised tonic-clonic and partial seizures. Tegretol Prolonged Release is indicated in newly diagnosed patients with epilepsy and in those patients who are uncontrolled or unable to tolerate their current anti-convulsant therapy.

Note: Carbamazepine is not usually effective in absences (petit mal) and myoclonic seizures. Moreover, anecdotal evidence suggests that seizure exacerbation may occur in patients with atypical absences.

The paroxysmal pain of trigeminal neuralgia.

For the prophylaxis of manic-depressive psychoses in patients unresponsive to lithium therapy.

Route of administration: Oral
Molecule: carbamazepine

Patients' opinions on Tegretol Prolonged Release

In brief

General satisfaction level: 4.00/10 Learn more

Treatment's effectiveness: 4.00/10 Learn more

Ease of use: 5.00/10 Learn more

Adherence to prescription: 5.00/10 Learn more

Detected side effects: 10.00/10 Learn more

Improvement in the quality of life: 4.00/10 Learn more

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community

on 14/04/2019

Side effects became too much to carry on eith treatment and pain level weren't under control

Your message

Conditions related to this medication

Fact sheet


See the fact sheet